Yes to Life
We provide information to guide people with cancer through the confusing options for care. Our aim is to help them make informed decisions.
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 23 | Founded | 6 months ago | Last Issue | 9 days ago |
| Active | |||||
Read this Newsletter
yestolifecharity.substack.comLatest Issues
Prostate Prospective
Professor Robert Thomas shares the significant findings from his latest prospective prostate cancer trial.
Professor Robert Thomas has an unrivalled track record when it comes to creating high-quality trials for lifestyle interventions for...
Mental Wealth
Dr Rani Bora has been on a journey to find meaningful ways to help people facing a mental crisis.
After many years in mainstream psychiatry, Dr Bora concluded that there must be better ways to support people than simply suppressing their s...
Intravenous Vitamin C Update: Shining a spotlight on progress in human clinical research in pancreatic and ovarian cancers
Ovarian and pancreatic cancers are universally agreed in the clinical oncology setting to be aggressive and to carry the worst prognosis when it comes to survival (1). There is so much work to be done here to improve the treatment and survi...
Prostate Proposition
Mark Lintern, architect of the Cell Suppression Theory of Cancer shares his recent insights into the nature of prostate cancer.
Prostate cancer has tended to be an anomaly amongst cancer types, failing to support even the most accurate the...
How Did I Get Cancer?
Almost everyone has been touched by cancer nowadays whether it is friends, family, or yourself. It can be a devastating disease physically, but often overlooked is the question that plagues the cancer survivor – How did this happen to me? W...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Yes to Life.
| Subscribers | Engagement | 73 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
With our holistic approach, Yes to Life emphasises the importance of the mental, emotional and spiritual state of those with cancer. Along with physical needs, we feel these should be considered as central to any treatment programme.
Frequently Asked Questions
How can I access the email archive for Yes to Life?
You can find recent issues that have been published by Yes to Life on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Yes to Life have?
To see how many people subscribe to Yes to Life, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Yes to Life?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Yes to Life as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Yes to Life?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Yes to Life using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Yes to Life?
Scroll up to where it says Related Newsletters to see other publications like Yes to Life. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Yes to Life?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.